{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:42:00Z","timestamp":1787499720073,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jacep.2020.11.027","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T01:44:44Z","timestamp":1617241484000},"page":"642-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative Efficacy of Dofetilide Versus Amiodarone in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"7","author":[{"given":"Ghanshyam","family":"Shantha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Latchamsetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiqa","family":"Batul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cunnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krit","family":"Jongnarangsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Frank","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Morady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2020.11.027_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.hrthm.2019.06.007","article-title":"Antiarrhythmic drug therapy and all-cause mortality after catheter ablation of atrial fibrillation: a propensity-matched analysis","volume":"16","author":"Shantha","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2020.11.027_bib2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/01.CIR.94.7.1592","article-title":"Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans","volume":"94","author":"D\u00e9molis","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2020.11.027_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9149(92)90996-C","article-title":"Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris","volume":"69","author":"Sedgwick","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.CIR.102.21.2665","article-title":"Cardiovascular drugs. Dofetilide","volume":"102","author":"Mounsey","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2020.11.027_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bjp.0705880","article-title":"Evidence for gender differences in electrophysiological properties of canine Purkinje fibres","volume":"142","author":"Abi-Gerges","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacep.2020.11.027_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hrthm.2018.01.027","article-title":"Dofetilide dose reductions and discontinuations in women compared with men","volume":"15","author":"Pokorney","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2020.11.027_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-8703(99)70363-7","article-title":"Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group","volume":"137","author":"N\u00f8rgaard","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2020.11.027_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2020.11.027_bib11","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jacep.2020.11.027_bib12","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1097\/MJT.0000000000000793","article-title":"Dofetilide-induced severe hepatotoxicity","volume":"25","author":"Subedi","year":"2018","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacep.2020.11.027_bib13","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/cc2160","article-title":"Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage","volume":"7","author":"Fukui","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.jacep.2020.11.027_bib14","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"27","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2020.11.027_bib15","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1113\/jphysiol.2007.150367","article-title":"Acute effects of oestrogen on the guinea pig and human Ikr channels and drug-induced prolongation of cardiac repolarization","volume":"586","author":"Kurokawa","year":"2008","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jelectrocard.2017.02.001","article-title":"Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting","volume":"50","author":"Marill","year":"2017","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1345\/aph.1D465","article-title":"Phase IV trial evaluating the effectiveness and safety of dofetilide","volume":"38","author":"Guanzon","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacep.2020.11.027_bib18","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1345\/aph.1Q159","article-title":"Dofetilide dose calculation errors in elderly associated with use of the Modification of Diet in Renal Disease equation","volume":"45","author":"Denetclaw","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacep.2020.11.027_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10840-018-0476-2","article-title":"Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation","volume":"54","author":"Naksuk","year":"2019","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1540-8159.2005.00179.x","article-title":"Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes","volume":"28","author":"Reiffel","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/CIRCEP.114.002339","article-title":"Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter","volume":"8","author":"Abraham","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3949\/ccjm.68.4.353","article-title":"Dofetilide (Tikosyn): a new drug to control atrial fibrillation","volume":"68","author":"Saliba","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jacep.2020.11.027_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0018578717738079","article-title":"Aacute hepatocellular jaundice after dofetilide initiation: a case report","volume":"53","author":"Rose","year":"2018","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.jacep.2020.11.027_bib24","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacep.2020.11.027_bib25","first-page":"471","article-title":"Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation","volume":"67","author":"Qin","year":"2016","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacep.2020.11.027_bib26","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/euhj.1999.2039","article-title":"Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study","volume":"21","author":"Bianconi","year":"2000","journal-title":"Eur Heart J"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X20313025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X20313025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:29:07Z","timestamp":1762500547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X20313025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2405500X20313025"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2020.11.027","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Efficacy of Dofetilide Versus Amiodarone in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2020.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}